1,1-Cyclohexanediacetic acid

We are 1,1-Cyclohexanediacetic acid CAS:4355-11-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1,1-Cyclohexanediacetic acid
CAS.NO:4355-11-7
Synonyms:1,1-Cyclohexanediacetic acid
Cyclohexyldiaceticacid
Cyclohexanediacetic acid
3,3-pentamethyleneglutaric acid
Cyclohexane-1,1'-diacetic acid
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 405.7±18.0 °C at 760 mmHg
Melting Point 67-70 °C(lit.)
Molecular Formula C10H16O4
Molecular Weight 200.232
Flash Point 213.3±17.7 °C
Vapour Pressure 0.0±2.0 mmHg at 25°C
Index of Refraction 1.495
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Gabapentin(CAS:60142-96-3).

1,1-Cyclohexanediacetic acid


Related News: The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.Disodio uridina-5'-monofosfato CAS:3387-36-8 “Once these risks have been identified then a project team can be put together combining the necessary expertise to provide the integrated services and tailored support to ensure continuity of supply from beginning to end.”473927-69-4 Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.tert-butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate CAS:83056-79-5 Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.“We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”

Related Products
Product Name
2,6-Dimethylphenol View Details
(E)-3-(5-nitrocyclohexen-1-yl)prop-2-enoic acid View Details
1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene View Details
Bis(Tetramethylene)Fluoroformamidinium Hexafluorophosphate manufacturer Benzyltriethylammonium Bromide Cas:5197-95-5 manufacturer Ethyl 3-Bromopropionate manufacturer 1,4-Difluoro-2-methyl-5-nitrobenzene manufacturer 4-benzhydryloxy-1-methylpiperidine,hydrochloride manufacturer